ConCallIQ
Go Pro
PARKMEDIWORLD Diversified 2026-04-??

Park Medi World Ltd — Q4 FY26

Park Medi World delivered its strongest year ever in FY26, with revenue of ₹1,679 Cr (+21% YoY), EBITDA of ₹444 Cr (+20% YoY), and PAT of ₹274 Cr (+27% YoY).

bullish high
Compare with...
Revenue ₹460 Cr +21%
EBITDA ₹444 Cr +20%
PAT ₹77 Cr +27%
EBITDA Margin 28%
Duration 75 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Elevated receivable days from government payers

92% of debtors are from central government schemes; receivable days improved to 129 but remain high. Further reduction depends on government process changes.

medium · analyst_question
R

Execution risk in greenfield hospital ramp-up

New greenfield units (e.g., Panchkula, Mohali) may take 12-15 months to breakeven and 3-4 years for full recovery, potentially dragging near-term margins.

medium · management_commentary
R

CGHS rate hike dependency and timing uncertainty

While the rate revision is positive, full impact may only be visible from Q1 FY27 onwards, and actual flow-through depends on adoption by various central agencies.

low · management_commentary
R

Competitive pressure from other affordable healthcare providers

Management noted few competitors have replicated Park's model at scale, but any new entrant with similar low-capex strategy could intensify competition.

low · analyst_question